Developing Novel Strategies for Personalized Treatment and Prevention of ALS: Leveraging the Global Exposome, Genome, Epigenome, Metabolome, and Inflammasome with Data Science in a Case/Control Cohort
Getting access
Committee review Disease-Specific (Amyotrophic Lateral Sclerosis, IRB, PUB, COL, NPU) (DS-ALS-IRB-PUB-COL-NPU)
- Apply at
- https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs004288.v1.p1
- Ethics
- IRB / ethics approval required
- Agreement
- Data use agreement
- Cost
- No charge
- Renewal
- Every 1 year
From the operator’s published policy metadata.
About this database
| Last updated | 2026-09-11 |
|---|